Sanofi · 1 day ago
Global Head, Patient-Driven Outcomes Solutions
Morristown, NJ
Full-time
Hybrid
Director/Executive
15+ years expSanofi is an R&D-driven, AI-powered biopharma company committed to improving people’s lives. As Global Head of Patient-Driven Outcomes Solutions, you will lead a global team focused on integrating patient priorities into clinical program evidence generation, leveraging digital health and AI to transform outcomes capabilities.
Health CareLife SciencePharmaceuticalTherapeutics
Responsibilities
Manage, and direct, the Head of, and team, of Clinical Outcomes Assessment Scientists with dotted line reporting responsibilities for the digital biomarker and ePRO teams in Clinical Sciences & Operations
Define and lead Sanofi’s global strategy for patient-driven outcomes across all therapeutic areas to deliver best in class products with recognized value by patients, HCP, regulators and payers through the democratization of the evidence generated
Position PDOS, as part of the patient disease strategy, that links early evidence generation to labeling, regulatory and payer decision making
Serve as a key advisor to R&D leadership, and project teams, on integrating patient perspectives into clinical development evidence generation in a manner that reflect industry leading modeling and measurement capabilities
Develop a high performing team of clinical outcomes scientists, expert in digital capabilities and novel frameworks of measurement
Build and lead a high-performing, cross-functional team of experts in PROs, digital health, AI, and patient engagement
Foster a culture of collaboration, inclusion, and continuous learning
Responsible for establishing a best in class, industry COA roadmap using digital capabilities to differentiate, de-risk and increase value of pipeline
In collaboration with Evidence Generation & Decision Sciences, therapeutic areas, eDevelopment and Clinical Sciences & Operations, lead the next generation capabilities in:
Digital health technologies (e.g., wearables, mobile apps, remote sensors) into clinical trials as tools to capture real-time, real-world patient data
State of the art modeling and simulation capabilities in pre-clinical to identify novel endpoints using AI/ML and advanced analytics
Approaches to enhance patient stratification, endpoint sensitivity, and personalized evidence generation
Registries, natural history studies and other real world evidence solutions to inform early research and development strategies
Drive the COA related real-world evidence strategy to increase differentiation of assets and de-risk clinical trial outcomes, reduce complexity in evidence generation and support product value demonstration by way of the patient disease strategy for each indication and asset
Advance conceptual modeling and dossier authoring using digital capabilities
Identify, develop and implement next generation capabilities to advance COA value and evidence generation and recognition
Ensure patient-driven outcomes strategies are industry leading and are embedded in clinical trial design, aligned with global regulatory and HTA expectations
Ensure digital solutions for COAs (eg, ePRO/DBM) are effectively integrated into clinical trials in a manner that reflects ease of implementation and a positive experience for trial sites and patient participants
Lead the development of evidence packages that include COAs, digital endpoints, and RWE for global regulatory and payer submissions
Partner with Regulatory Affairs to engage with health authorities on the qualification of novel digital and patient-centric measures and expand PED related evidence generation value recognition
Collaborate directly with the Head of Market Access to establish highly effective strategies that link outcomes to value assessments across key markets
Represent Sanofi in global consortia, regulatory workshops, and scientific forums focused on digital health and patient-centered outcomes
Build strategic partnerships with technology providers, academic institutions, and patient advocacy organizations to deliver best in class outcomes solutions for patients
Drive Sanofi’s recognized thought leadership internally and externally in the domains of patient driven outcomes solutions and act as a key leader in evolving integrated patient engagement across the company
Qualification
Required
Advanced degree in a relevant discipline related to health economics, qualitative and quantitative research (COAs)
15+ years in the pharmaceutical, biotech, or healthcare industry
10+ years in a senior leadership role focused on patient-driven outcomes, digital health, and exposure to implications of integrating real-world evidence
Significant demonstrated experience in digital innovation related to COA; including evidence of having successfully driven innovation for value creation
Proven track record of successful submissions incorporating patient-centered outcomes
Recognized within industry as a thought leader in this domain
Deep understanding of clinical development, regulatory science, and clinical outcomes and health economics
Expertise in digital health technologies, AI/ML applications
Strong leadership, communication, and cross-functional collaboration skills
Experience working in a global, matrixed environment
Benefits
High-quality healthcare
Prevention and wellness programs
At least 14 weeks’ gender-neutral parental leave
Company
Sanofi
Sanofi is a global biopharma company focused on prescription drugs, vaccines, and treatments for chronic, rare, and infectious diseases.
10001+ employees
H1B Sponsorship
Sanofi has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (101)
2024 (68)
2023 (59)
2022 (78)
2021 (38)
2020 (38)
Funding
Current Stage
Public CompanyTotal Funding
$6.97BKey Investors
Blackstone Life SciencesEvotec
2025-10-28Post Ipo Debt· $3B
2025-06-17Post Ipo Debt· $1.74B
2025-03-05Post Ipo Debt· $1.59B
Leadership Team
Paul Hudson
Chief Executive Officer
Francois-Xavier Roger
Chief Financial Officer
Recent News
Maryland Daily Record
2026-01-22
2026-01-22
2026-01-22
Company data provided by crunchbase